Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2003
11/06/2003WO2003091214A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo
11/06/2003WO2003091212A1 Cinnamic acid amides
11/06/2003WO2003091202A1 Diketohydrazine derivative compounds and drugs contaiing the compounds as the active ingredient
11/06/2003WO2003090912A1 Pyrrolo-triazine aniline compounds useful as kinase inhibitors
11/06/2003WO2003090751A1 Pyrimidine-2, 4, 6-trione metallo-proteinase inhibitors
11/06/2003WO2003090691A2 Method and compositions for identifying anti-hiv therapeutic compounds
11/06/2003WO2003090690A2 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
11/06/2003WO2003090680A2 Novel phenyl derivatives as inducers of apoptosis
11/06/2003WO2003066889A3 Assay for acytyltransferase or deacetylase activity
11/06/2003WO2003035626A3 Azole derivatives and pharmaceutical compositions containing them
11/06/2003WO2003035005A3 Heteroindanes: a new class of potent cannabimimetic ligands
11/06/2003WO2003032903A3 Trisubstituted triazines compounds with antitubulin activity
11/06/2003WO2003026587A3 Compounds useful for treating hepatitus c virus
11/06/2003WO2003006506A3 Protease inhibitor conjugates and antibodies useful in immunoassay
11/06/2003WO2002094799A3 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/06/2003WO2002076979A8 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
11/06/2003WO2002070509A8 Antagonists of mcp-1 function and methods of use thereof
11/06/2003WO2002064567A3 Substituted carboxamides as inhibitors of factor xa
11/06/2003WO2002059117A8 Piperazine- and piperidine-derivatives as melanocortin receptor agonists
11/06/2003WO2002059108A8 Melanocortin receptor agonists
11/06/2003WO2002059107A8 Substituted piperidines/piperazines as melanocortin receptor agonists
11/06/2003US20030208078 Heterocyclic amines administered to mammals for detection of nervous system disorders
11/06/2003US20030208075 Process for making chiral 1,4-disubstituted piperazines
11/06/2003US20030208069 Method for producing 8-methoxy-quinoline carboxylic acids
11/06/2003US20030208067 Inhibitors of protein kinase for the treatment of disease
11/06/2003US20030207939 Novel 3-substituted urea derivatives and medicinal use thereof
11/06/2003US20030207922 Diketoacids useful as inhibitors of viral polymerases, in particular hepatitis C virus, RNA dependent RNA polymerase, hepatitis B virus polymerase and reverse transcriptase of human immunodeficiency virus
11/06/2003US20030207920 N-(heterocyclyl)benzene or pyridinesulphonamides as antithrombotic agents and anticoagulants
11/06/2003US20030207919 For treating, preventing, reducing inflammation, pain, fever,gastrointestinal disorders; decreasing gastrointestinal, renal and other toxicities resulting from use of nonsteroidal antiinflammatory drugs; multiplicity of compounds
11/06/2003US20030207917 1,4-di-substituted piperidines, some of which have M2 selectivity even higher than that of 3-alpha-chloroimperialine for treating cognitive disorders such as Alzheimer's disease
11/06/2003US20030207914 For treatment of tumors and/or cancerous cell growth mediated by raf kinase
11/06/2003US20030207913 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease
11/06/2003US20030207909 Therapeutic acridone and acridine compounds
11/06/2003US20030207897 Selective inhibitors of cyclooxygenase-2
11/06/2003US20030207896 Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts
11/06/2003US20030207893 Antihistamines such as (5-Chloro-1H-indol-2-yl)-(4-methyl-piperazin-1-yl)-methanone, used as antiinflammatory, antiarthritic or bronchodilator agents and/or immunology modulators
11/06/2003US20030207892 Heterocyclic amines such as N-(Pyridin-4-yl)-(1-(4-fluoro-benzyl)indol-3-yl)glyoxylamide, used for prophylaxis of skin disorders, rheumatic diseases or arthritis
11/06/2003US20030207887 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives
11/06/2003US20030207883 Indazole benzimidazole compounds
11/06/2003US20030207882 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents
11/06/2003US20030207878 Drugs used as angiogenesis inhibitors, vascular permeability or endothelial growth factor antagonists, for prophylaxis of cancer, diabetes, psoriasis, arthritis, autoimmune diseases, inflammation or scar formation
11/06/2003US20030207876 3-Azabicyclo[3.1.0]hexane derivatives useful in therapy
11/06/2003US20030207875 Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators
11/06/2003US20030207868 Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
11/06/2003US20030207862 Which are effective antimicrobial agents such as aminoethylpyrrolidinyl))-1-ethyl-1,4-dihydro-8-chloro-6-hydrox y- 4-oxo-3-quinolinecarboxylic acid;
11/06/2003US20030207861 Novel compounds as NS3-serine protease inhibitors of hepatitis C virus
11/06/2003US20030207860 Neuropeptide Y Y5 receptor antagonists
11/06/2003US20030207858 Selective modulators of the nicotinic acetylcholine receptor useful in the treatment of pain, Alzheimer's disease, memory loss or dementia or loss of motor function.
11/06/2003US20030207857 Phenyl heterocyclyl ethers
11/06/2003CA2483636A1 3,4-dihydroquinolin-2(1h)-one compounds as nr2b receptor antagonists
11/06/2003CA2483515A1 Novel thiol derivative, method for producing the same and use thereof
11/06/2003CA2483504A1 4,4-(disubstituted)piperidine derivatives with ccr3 antagonism
11/06/2003CA2483500A1 Pyrimidine-2, 4, 6-trione metallo-proteinase inhibitors
11/06/2003CA2483314A1 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
11/06/2003CA2483091A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo' b! thiophene-2-carboxylic acid derivatives as interieukin-4 gene expression inhibitors
11/06/2003CA2481449A1 Method and compositions for identifying anti-hiv therapeutic compounds
11/06/2003CA2481285A1 Non nucleoside reverse transcriptase inhibitors
11/06/2003CA2480293A1 New piperidinyl-alkylamino-pyridazinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing said compounds
11/05/2003EP1359152A2 Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
11/05/2003EP1359146A2 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents
11/05/2003EP1359144A1 Method for the preparation of bismaleimides
11/05/2003EP1358909A1 Heteroaryl-phenyl derivatives as factor xa inhibitors for use as antithrombotic and anticoagulant agents
11/05/2003EP1358184A1 Substituted alkylamine derivatives and methods of use
11/05/2003EP1358180A2 Naphthostyril derivatives and their use as inhibitors of cyclin-dependent kinases
11/05/2003EP1358179A1 Synthesis method and intermediates of pyridin-2-yl-methylamine
11/05/2003EP1358178A2 Sulfonamide lactam inhibitors of factor xa
11/05/2003EP1358177A2 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
11/05/2003EP1358165A1 Imidazole derivatives
11/05/2003EP1358161A2 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them
11/05/2003EP1358158A1 N-substituted tetrahydropyridines and their use as pesticides
11/05/2003EP1358157A1 Carbazole derivatives and their use as neuropeptide y5 receptor ligands
11/05/2003EP1358154A2 Pyrrolidine derivatives, their preparation and their use as inhibitors of neuraminidases
11/05/2003EP1268468B1 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline mesylat and polymorphs
11/05/2003EP1212300B1 Azacycloalkanone serine protease inhibitors
11/05/2003EP1154996B1 Aroyl aminoacyl pyrroles for use in the treatment of neuropathic pain
11/05/2003EP1068194B1 Pde iv inhibiting pyridine derivatives
11/05/2003EP0989985B1 Fused polycyclic 2-aminopyrimidine derivatives as protein kinase inhibitors
11/05/2003EP0902007B1 Chalcone derivatives and drugs containing the same
11/05/2003CN1454211A Nitrogen containing heterobicycles as factor xa inhibitors
11/05/2003CN1454210A 嘧啶衍生物 Pyrimidine derivatives
11/05/2003CN1454086A High affinity small molecule C5A receptor modulators
11/05/2003CN1126737C Novel pyrrole compound, its preparation and pharmaceutical composition containing the same
11/05/2003CN1126534C Intracoronary stents fix mould containing quinazolinone derivatives
11/04/2003US6642385 Synthesis of 4-(piperidyl)(2-pyridyl)methanone-(E)-O-methyloxime and salts
11/04/2003US6642383 Of the class 3,3,5,5-tetramethyl-2-oxo-1,4-piperazine, polymers thereof; stabilizers for thermoplastic organic polymers, coating compositions or photographic materials
11/04/2003US6642255 Substituted carbocyclic or heterocyclic hydroxamic acid derivatives, e.g., (3R,4S)-N-hydroxy-1-methyl-3-(((4-((2-methyl-4 -quinolinyl)methoxylphenyl)sulfonyl)methyl)-4-piperidinecarboxamide
11/04/2003US6642254 Heterocyclic compounds and their therapeutic use
11/04/2003US6642253 Thrombin inhibitors comprising an aminoisoquinoline group
11/04/2003US6642252 Anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer.
11/04/2003US6642251 Antitumor, 2-indolinone derivatives
11/04/2003US6642247 Treting anxiety, stress, depression, trauma, Alzheimer's mediated memory loss, epilepsy, arterial blood pressure disorders, obesity, acute pain, chronic pain, Na+ excretion, control of water balance, and symptoms associated with drug
11/04/2003US6642242 Quinoline and quinazoline compounds useful in therapy
11/04/2003US6642240 Treating emesis in a mammal
11/04/2003US6642237 Inhibitors of HIV protease and inhibitors of HIV replication, used in the prevention or treatment of infection by HIV and treatment for AIDS
11/04/2003US6642234 Acrylonitrile compounds
11/04/2003US6642232 3-[4-Substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2- indolinone derivatives as kinase inhibitors
11/04/2003US6642228 α1b-adrenergic receptor antagonists
11/04/2003US6642226 Such as cis-(3,5-bis-trifluoromethyl-phenyl)-(4-(4-methyl-piperazin-1-yl),-3-phenyl -piperidin-1-yl)-methanone; for treatment of diseases related to neurokinin receptors
11/04/2003US6642225 Diazacycloalkanedione derivatives
11/04/2003US6642224 Activated blood coagulation factor X inhibitors